Home » AUREON LABORATORIES SECURES $20 MILLION IN SERIES B VENTURE CAPITAL FUNDING
AUREON LABORATORIES SECURES $20 MILLION IN SERIES B VENTURE CAPITAL FUNDING
Aureon Laboratories (formerly Aureon Biosciences) announced today that it has closed on a Series B round of venture capital financing, which secured $20 million for the Company. The group of investors participating in the financing included Atlas Venture, Sprout Group, Pfizer, and a consortium of European investors with expertise in the medical diagnostics industry. Aureon Laboratories specializes in the creation of next-generation tissue analysis by integrating clinical, micro-anatomic and molecular profiles of disease.
BioSpace (http://www.biospace.com/news_story.cfm?StoryID=20786220&full=1)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May